Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Therapieumstellung
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1993) 82 (Suppl. 2): 22–28.
Published Online: 14 November 2008
... vollständig unter Kontrolle gebracht oder zumindest geschwächt werden; 2) die Besserungen stellen sich gewöhnlich ein paar Tage bis Wochen nach Beginn der Cilazapriltherapie ein, und 3) die Therapieumstellung von einem bisher verwen-deten ACE-Hemmer oder sogar ein «Placebo»-Effekt der Studie an sich kann...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1993) 82 (Suppl. 2): 1–8.
Published Online: 14 November 2008
.... Cilazapril ACE-Hemmer Therapieumstellung Cardiology 1993;82(suppl 2): 1-8 M. Reliaia E. Török3 E. Hajdua St. Rietikerb G. Easseyb Th. Szucsb A. Schneeweissc Ungarisches Institut für Kardiologie. Budapest, Ungarn; Bereich Pharma. F. Hoffmann-La Roche. Basel, Schweiz; und Cardiovascular Research...